Under Sir Keith’s leadership, Cambridge has become a major centre for clinical research, complementing the University’s longstanding strengths in basic biomedical science. He is a fellow of the Royal Society, a founder Fellow of the Academy of Medical Sciences and its second President.
From 2006-2008 Sir Keith was Interim Director of the MRC’s National Institute for Medical Research and initiated discussions which led to the establishment of the UK Centre for Medical Research and Innovation, the Francis Crick Institute. Sir Keith is currently a consultant in Clinical Science and Translational Medicine for the Institute.
From 2005-2016 Sir Keith was a Senior Consultant to the President of Pharmaceuticals R&D at GlaxoSmithKline and has served on the science advisory boards of various biotechnology companies including Cambridge Antibody Technology.